EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Disabled 2 (Dab2) Regulates Tumour Progression in Skin Squamous Cell Carcinoma

Sayoni Roy, Darshan Mehta iD, Suruchi Sawant, Sanjeev K Waghmare iD

Experimental Dermatology · 2024

DOI: 10.1111/exd.70009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Dermatology, 2024. Verfasst von Sayoni Roy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell Biology Group, Waghmare Lab, Cancer Research Institute, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memor…. Hauptthemen laut MEDLINE: Skin Neoplasms, Carcinoma, Squamous Cell, Mice, Knockout, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Atomic Energy, Government of India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dab2 is an endocytic adaptor protein involved in various physiological processes and signaling pathways. Dab2 is deregulated in various cancers; however, its role in skin squamous cell carcinoma ( SCC) has not been elucidated yet. In the present study, we used the DMBA/TPA induced murine skin carcinogenesis model to examine the role of Dab2 in skin tumour progression. We generated tamoxifen inducible Dab2 conditional knockout system for our study. Loss of Dab2 led to delayed papilloma initiation and reduced papilloma burden. Delayed papilloma initiation was due to reduce proliferative potential of the papillomas due to Dab2 loss. Furthermore, while the WT papillomas progressed to SCC, the papillomas formed in Dab2 cKO mice failed to undergo malignant conversion to SCC. Dab2 cKO tumours showed reduced expression of K8, a marker for aggressive tumour. Moreover, Dab2 ckO tumours failed to undergo EMT as shown by reduced expression of Vimentin and Twist1. Dab2 cKO tumours also showed reduced expression of Sox2, a stem cell marker. Furthermore, qPCR analysis showed upregulation of Dab2 expression in the human skin cancer cell lines as compared to normal human skin keratinocytes. In patients, TCGA data analysis of skin cancer melanoma (SKCM) showed a trend where high levels of Dab2 correlated with poor overall survival. The present study shows that Dab2 promotes tumour progression in skin SCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsCarcinoma, Squamous CellMice, KnockoutAdaptor Proteins, Signal TransducingDisease ProgressionAnimalsHumansMiceCell Line, TumorApoptosis Regulatory ProteinsPapillomaEpithelial-Mesenchymal TransitionSOXB1 Transcription Factors

Stichwörter der Autor:innen

Dab2EMTTCGApapillomaproliferationsquamous cell carcinoma

Substanzen

Adaptor Proteins, Signal TransducingDab2 protein, mouseDAB2 protein, humanApoptosis Regulatory ProteinsSOXB1 Transcription Factors

Autor:innen und Institutionen

  • Stem Cell Biology Group, Waghmare Lab, Cancer Research Institute, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, Maharashtra, India.
  • Homi Bhabha National Institute, Training School Complex, Mumbai, India.

ORCID-Profile: Darshan Mehta, Sanjeev K Waghmare

Förderung

  • Department of Atomic Energy, Government of India

Zitieren

APA

Roy, S., Mehta, D., Sawant, S., & Waghmare, S. K. (2024). Disabled 2 (Dab2) Regulates Tumour Progression in Skin Squamous Cell Carcinoma. Experimental Dermatology. https://doi.org/10.1111/exd.70009

Vancouver

Roy S, Mehta D, Sawant S, Waghmare SK. Disabled 2 (Dab2) Regulates Tumour Progression in Skin Squamous Cell Carcinoma. Experimental Dermatology. 2024. doi:10.1111/exd.70009

BibTeX
@article{Roy2024,
  author = {Roy, Sayoni and Mehta, Darshan and Sawant, Suruchi and Waghmare, Sanjeev K},
  title = {Disabled 2 (Dab2) Regulates Tumour Progression in Skin Squamous Cell Carcinoma},
  journal = {Experimental Dermatology},
  year = {2024},
  doi = {10.1111/exd.70009}
}
Kostenlos starten →